metaraminol has been researched along with disulfiram in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Porter, CC; Torchiana, ML | 1 |
| Haefely, W | 1 |
| Boukma, SJ; Johnson, GA; Kim, EG | 1 |
| Gulati, OD; Parikh, HM; Ringe, SY; Sherlekar, ML | 1 |
1 review(s) available for metaraminol and disulfiram
| Article | Year |
|---|---|
[Drugs with effect on the adrenergic nerve fiber].
Topics: Aminocaproates; Amitriptyline; Amphetamine; Bretylium Compounds; Chlorpromazine; Disulfiram; Dopamine; Ephedrine; Guanethidine; Humans; Imipramine; Mental Disorders; Metaraminol; Methyldopa; Methyltyrosines; Monoamine Oxidase Inhibitors; Neurons; Norepinephrine; Octopamine; Prenylamine; Reserpine; Sympathetic Nervous System; Sympathomimetics; Tetrabenazine; Tyramine; Vascular Diseases | 1968 |
5 other study(ies) available for metaraminol and disulfiram
| Article | Year |
|---|---|
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
4,4,6-trimethyl-3,4-dihydropyrimidine-2-thiol, an effective inhibitor of dopamine-beta-hydroxylation in vivo.
Topics: Acetaldehyde; Amino Alcohols; Animals; Benzyl Compounds; Blood Pressure; Brain Chemistry; Carbon Isotopes; Cattle; Dihydroxyphenylalanine; Disulfiram; Dopamine; Ethanol; Ethylamines; Female; Heart; Hydrazines; Iodine; Male; Metaraminol; Methyldopa; Methyltyrosines; Mice; Mixed Function Oxygenases; Monoamine Oxidase Inhibitors; Myocardium; Norepinephrine; Normetanephrine; Propylthiouracil; Pyrimidines; Rats; Reserpine; Stereoisomerism; Sulfhydryl Compounds; Thyroid Gland; Tyramine | 1971 |
In vivo inhibition of dopamine beta-hydroxylase by 1-phenyl-3-(2-thiazolyl)-2-thiourea (U-14,624).
Topics: Adrenal Glands; Adrenalectomy; Animals; Brain; Brain Chemistry; Carbon Isotopes; Catecholamines; Disulfiram; Dopamine; Dopamine Antagonists; Hydrolases; Male; Metaraminol; Mice; Monoamine Oxidase Inhibitors; Myocardium; Norepinephrine; Rats; Species Specificity; Thiazoles; Thiourea; Time Factors; Tritium; Tyrosine | 1970 |
An investigation of alpha-methyl amino-acids and their derivatives on isolated tissue preparations.
Topics: Amino Acids; Animals; Cocaine; Disulfiram; Dopamine; Ear, External; Heart; Ileum; In Vitro Techniques; Metaraminol; Methyldopa; Methyltyrosines; Normetanephrine; Perfusion; Rabbits; Rats; Reserpine; Sodium; Tyramine | 1970 |